Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04147832 · ClinicalTrials.gov registry record
Epividian / AHF: Positive Pathways - HIV Retention in Care
A clinical trial, sponsored by Epividian.
- Completed
- Registry status
- 10,521
- Enrollment target
NCT04147832 is a clinical trial that has completed, run by Epividian. The registered enrollment target is 10,521 participants.
The verdict
NCT04147832 has completed, sponsored by Epividian.
- COMPLETED
- Registry status
- 10,521 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effectiveness of a clinical decision support system (CDSS) combined with enhanced patient contact to retain HIV+ patients in care with AIDS Healthcare Foundation. Specifically, the study aims to evaluate the effectiveness of having the patient's primary caregiver (or dedicated case manager) telephone the patient when the patient is identified as a significant risk to loss of follow-up (at-risk patients) based upon pre-defined criteria. The secondary objective Gain a better understanding about the implementation of the study's procedures in clinical practice by evaluating survey responses delivered to participating healthcare providers and AHF staff members engaging with the study's intervention.
Interventions
- OTHER Alert to provider
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,521 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2021-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04147832
The ClinicalTrials.gov registry entry for NCT04147832 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,521 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Epividian, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alert to provider is the first listed.
NCT04147832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04147832 about?
NCT04147832 is a clinical study titled "Epividian / AHF: Positive Pathways - HIV Retention in Care". The primary objective of this study is to evaluate the effectiveness of a clinical decision support system (CDSS) combined with enhanced patient contact to retain HIV+ patients in care with AIDS Healthcare Foundation. Specifically, the study aims to evaluate the effectiveness of having the patient's...
What is the current status of trial NCT04147832?
This trial is currently completed. The enrollment target is 10,521 participants. The study started on 2020-10-05. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT04147832?
The interventions under investigation include: Alert to provider (OTHER).
Who is sponsoring clinical trial NCT04147832?
This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.